Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in TAK held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Capital Research Global Investors | 19.3M | $309.3M | +1.0% | 0.607% | 0.04% |
| 2 | FMR LLC | 9.6M | $153.9M | +34.9% | 0.302% | 0.01% |
| 3 | MORGAN STANLEY | 7.0M | $112.1M | +8.1% | 0.220% | 0.01% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.1M | $97.0M | -5.8% | 0.190% | 0.14% |
| 5 | GOLDMAN SACHS GROUP INC | 5.1M | $82.2M | -8.8% | 0.161% | 0.01% |
| 6 | BRANDES INVESTMENT PARTNERS, LP | 4.5M | $72.8M | +2.5% | 0.143% | 0.51% |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.7M | $59.8M | +19.8% | 0.117% | 0.03% |
| 8 | BlackRock, Inc. | 3.7M | $59.1M | +16.1% | 0.116% | 0.00% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 2.6M | $41.2M | -14.1% | 0.081% | 0.06% |
| 10 | Qube Research & Technologies Ltd | 2.2M | $35.4M | — | 0.069% | 0.03% |
| 11 | FIRST TRUST ADVISORS LP | 2.1M | $33.9M | +7.3% | 0.067% | 0.02% |
| 12 | D. E. Shaw & Co., Inc. | 2.0M | $32.9M | -21.3% | 0.064% | 0.02% |
| 13 | MANAGED ASSET PORTFOLIOS, LLC | 1.8M | $29.2M | +1.4% | 0.057% | 3.34% |
| 14 | NORTHERN TRUST CORP | 1.7M | $27.9M | -11.3% | 0.055% | 0.00% |
| 15 | VAN ECK ASSOCIATES CORP | 1.7M | $26.8M | -25.9% | 0.053% | 0.02% |
| 16 | ENVESTNET ASSET MANAGEMENT INC | 1.6M | $25.6M | +13.2% | 0.050% | 0.00% |
| 17 | AQR CAPITAL MANAGEMENT LLC | 1.5M | $24.5M | +70.6% | 0.048% | 0.01% |
| 18 | Quantinno Capital Management LP | 1.4M | $22.5M | +8.8% | 0.044% | 0.03% |
| 19 | WELLS FARGO & COMPANY/MN | 1.2M | $18.4M | +1.3% | 0.036% | 0.00% |
| 20 | MILLENNIUM MANAGEMENT LLC | 1.1M | $16.8M | — | 0.033% | 0.01% |
| 21 | CITADEL ADVISORS LLC | 927K | $14.9M | -57.2% | 0.029% | 0.00% |
| 22 | UBS Group AG | 911K | $14.6M | -66.7% | 0.029% | 0.00% |
| 23 | Crossmark Global Holdings, Inc. | 784K | $12.6M | +0.9% | 0.025% | 0.16% |
| 24 | JANE STREET GROUP, LLC | 769K | $12.3M | — | 0.024% | 0.00% |
| 25 | JPMORGAN CHASE & CO | 745K | $11.9M | +64.1% | 0.023% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in TAK — a direct measure of their conviction.
Filings activity in TAK during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 379 | +5.0% | 3.33% | +0.19 pp | $1.68B | 6.0% |
| Q1 2026 | 361 | +5.6% | 3.14% | +0.43 pp | $1.78B | +34% |
| Q4 2025 | 342 | +5.9% | 2.71% | 0.02 pp | $1.33B | 4.5% |
| Q3 2025 | 323 | +4.2% | 2.73% | 1.18 pp | $1.39B | 27% |
| Q2 2025 | 310 | +4.0% | 3.91% | +1.69 pp | $1.92B | +93% |
| Q1 2025 | 298 | +3.5% | 2.22% | 0.03 pp | $996M | +11% |
| Q4 2024 | 288 | 1.7% | 2.25% | 0.03 pp | $894M | 1.7% |
| Q3 2024 | 293 | — | 2.28% | — | $910M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TAK stock.
Based on Q2 2026 13F filings, institutional ownership of Takeda Pharmaceutical Company Limited stands at 3.3%, held across 379 reporting institutions.
Capital Research Global Investors is the largest reported institutional holder of TAK, with approximately 19,297,680 shares worth $0.31B as of Q2 2026.
Yes — 4 widely-followed marquee investors appear among the top 25 institutional holders of TAK, including RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC.
Our composite Smart Money Score for TAK is 64 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
61 institutions opened new positions in TAK during Q2 2026, while 41 fully exited. 83 added to existing positions and 222 trimmed.
TAK institutional ownership rose by 0.19 percentage points quarter-over-quarter, with a net change of +18 holders.
The top 10 institutions account for 61.0% of all reported 13F value in TAK, and the top 25 account for 80.3%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Takeda Pharmaceutical Company Limited (TAK) Institutional Ownership